HealthEquity, Inc. (NASDAQ:HQY) Receives $110.71 Consensus PT from Analysts

HealthEquity, Inc. (NASDAQ:HQY) has earned an average rating of “Moderate Buy” from the fourteen research firms that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $110.71.

A number of equities analysts recently weighed in on the stock. Royal Bank of Canada boosted their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. JMP Securities upped their target price on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. Bank of America lifted their price target on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Barrington Research upped their price objective on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. Finally, Mizuho assumed coverage on HealthEquity in a research note on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price for the company.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction on Monday, December 9th. The stock was sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the transaction, the director now directly owns 66,469 shares of the company’s stock, valued at $6,750,591.64. The trade was a 11.04 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 34,289 shares of company stock valued at $3,355,718. 2.20% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Paladin Wealth LLC bought a new position in HealthEquity in the 3rd quarter valued at about $39,000. Point72 Asia Singapore Pte. Ltd. bought a new position in HealthEquity in the second quarter valued at approximately $73,000. GAMMA Investing LLC raised its position in HealthEquity by 57.8% during the third quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock valued at $77,000 after purchasing an additional 344 shares in the last quarter. Quarry LP raised its position in HealthEquity by 418.8% during the third quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after purchasing an additional 1,089 shares in the last quarter. Finally, 1620 Investment Advisors Inc. bought a new stake in HealthEquity during the third quarter worth $112,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Stock Up 0.6 %

NASDAQ:HQY opened at $100.32 on Friday. HealthEquity has a twelve month low of $65.01 and a twelve month high of $105.82. The firm has a market capitalization of $8.69 billion, a price-to-earnings ratio of 92.04, a price-to-earnings-growth ratio of 1.08 and a beta of 0.54. The company has a quick ratio of 4.10, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock’s 50 day moving average price is $98.14 and its two-hundred day moving average price is $86.03.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.